Examkin

Soru

Zorluk: Çok zorPharmacologic Interventions

A 74-year-old woman is brought to the emergency department by emergency medical services after a witnessed generalized tonic-clonic seizure lasting 2 minutes. She is currently postictal, profoundly confused, and agitated. Her past medical history is significant for atrial fibrillation, major depressive disorder, diabetic peripheral neuropathy, and hypertension. Her home medications include apixaban, amitriptyline, fluoxetine, and metoprolol succinate. Her husband notes that she was recently prescribed tramadol for acute back pain and took her first two doses earlier today.

Vital signs are:
Temperature: 39.4°C (102.9°F)
Heart rate: 142/min
Blood pressure: 175/95 mm Hg
Respiratory rate: 22/min
SpO2: 96% on room air

Physical examination reveals a profusely diaphoretic and flushed woman. Pupils are 6 mm bilaterally and reactive to light. Bowel sounds are hyperactive. Neuromuscular examination is remarkable for significant hypertonia in the lower extremities, 4+ patellar reflexes bilaterally, and spontaneous, sustained ankle clonus.

An electrocardiogram demonstrates atrial fibrillation with a rapid ventricular response of 142/min and a QTc interval of 535 ms.

Which of the following pharmacologic interventions are indicated in the immediate management of this patient? (Select all that apply)

  1. Intravenous lorazepamCevap
  2. Oral cyproheptadineCevap
  3. C
    Intravenous physostigmine
  4. D
    Intravenous amiodarone
  5. E
    Intravenous ondansetron

Cevap

The correct interventions are intravenous lorazepam and oral cyproheptadine.
This patient is experiencing life-threatening serotonin syndrome, precipitated by the concurrent use of fluoxetine (SSRI), amitriptyline (TCA), and tramadol (SNRI/opioid). The classic presentation includes altered mental status, autonomic instability (hyperthermia, tachycardia, diaphoresis), and marked neuromuscular hyperactivity (hyperreflexia, spontaneous clonus). The immediate management involves discontinuing all serotonergic agents and providing supportive care. Intravenous benzodiazepines, such as lorazepam, are the first-line pharmacologic intervention. They effectively control agitation, decrease the hyperadrenergic state (thereby lowering heart rate and blood pressure), and reduce muscle hyperactivity, which is the primary driver of hyperthermia in this syndrome. Cyproheptadine, a 5-HT2A antagonist, is the specific antidote for serotonin syndrome and is indicated in moderate to severe cases that do not respond adequately to benzodiazepines and supportive care alone.

Adım Adım Çözüm

1
Analyze the patient's medication list and presentation.
The patient is taking fluoxetine, amitriptyline, and recently added tramadol. She presents with hyperthermia, autonomic instability, diaphoresis, hyperactive bowel sounds, hyperreflexia, and spontaneous clonus.
Identifying the toxidrome is the critical first step. The triad of neuromuscular excitation (clonus, hyperreflexia), autonomic stimulation (hyperthermia, tachycardia, diaphoresis), and altered mental status in the setting of multiple serotonergic agents strongly points to serotonin syndrome.
2
Determine the first-line pharmacologic management for serotonin syndrome.
Intravenous benzodiazepines (lorazepam) should be administered immediately.
Benzodiazepines blunt the hyperadrenergic state, control agitation, reduce the risk of further seizures, and decrease muscle contraction, thereby aiding in temperature reduction.
3
Identify indicated targeted antidotes.
Oral cyproheptadine should be administered.
Cyproheptadine is a first-generation histamine antagonist with non-specific 5-HT1A and 5-HT2A antagonistic properties. It is the targeted antidote of choice for moderate to severe serotonin syndrome.
4
Evaluate other options for contraindications and severe drug interactions.
Physostigmine, amiodarone, and ondansetron must be strictly avoided.
Physostigmine causes fatal asystole in TCA overdose. Amiodarone exacerbates the existing QTc prolongation (535 ms). Ondansetron worsens QTc prolongation and possesses serotonergic properties that can worsen the syndrome.

Anahtar Kavram

The diagnosis of serotonin syndrome in a polypharmacy patient requires immediate management with benzodiazepines and cyproheptadine, while strictly avoiding medications that prolong the QTc interval, precipitate arrhythmias (e.g., physostigmine with TCAs), or possess unrecognized serotonergic activity (e.g., ondansetron).
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru